Bottom line
Is MCARX a good fund? The bottom line
MCARX is the R2 share class of MFS Conservative Allocation Fund, an actively managed allocation / balanced mutual fund from MFS.
It charges 1.08% — about $108 a year on every $10,000 invested, more expensive than 66% of allocation / balanced funds we track.
It returned +9.3% over one year, +3.5% a year over five years, +5.7% a year over ten (as of Dec 31, 2025, per its prospectus).
With $3.6 billion in net assets and 22 holdings, its largest position is MFS Research Bond Fund (14.9%) and the top 10 make up 76.3% of the portfolio.
What stands out
- No front-end sales load
What to watch
- 5-year return in the bottom quarter of its category
- Concentrated: top 10 holdings are 76.3% of assets
- 12b-1 marketing fee of 0.5% a year
Updated Nov 19, 2026
What MCARX invests in
The fund's investment objective is to seek a high level of total return consistent with a conservative level of risk relative to the other MFS Asset Allocation Funds. (The MFS Asset Allocation Funds currently are MFS Conservative Allocation Fund, MFS Moderate Allocation Fund, MFS Growth Allocation Fund, and MFS Aggressive Growth Allocation Fund.)
The fund is designed to provide diversification among different asset classes by investing its assets in other mutual funds advised by MFS (Massachusetts Financial Services Company, the funds investment adviser), referred to as underlying funds. MFS selects the asset class allocations based on a strategic asset allocation process that takes into account a variety of factors, including historical risk and performance, projected performance, and other factors. MFS analyses of projected performance are primarily based on quantitative models using various inputs such as valuation metrics, growth rates, profitability, yields, and inflation. MFS may also consider current market conditions, its qualitative assessment of the risk/return characteristics of asset classes, and other factors in determining these allocations. MFS employs the strategic asset allocation process described above to…
From the fund's prospectus (filed Sep 25, 2026).
MCARX performance
| 1 yr | 5 yr | 10 yr | |
|---|---|---|---|
| MCARX | +9.3% | +3.5% | +5.7% |
| Allocation / Balanced median | +11.0% | +5.7% | +6.7% |
Source: Fund prospectus, as of Dec 31, 2025
What MCARX costs
On a $10,000 investment, MCARX's 1.08% expense ratio costs about $108 a year. The prospectus estimates $1,317 in total costs over 10 years (assuming 5% annual returns). The median allocation / balanced fund charges 0.91%.
MCARX top 10 holdings
| # | Holding | % of fund |
|---|---|---|
| 1 | MFS Research Bond Fund | 14.91% |
| 2 | MFS Inflation Adjusted Bond Fund | 9.98% |
| 3 | MFS Ltd Maturity Fund | 9.93% |
| 4 | MFS Government Securities Fund | 9.90% |
| 5 | MFS Global Opportunistic Bond Fund | 6.99% |
| 6 | MFS Value Fund | 5.96% |
| 7 | MFS Growth Fund | 5.30% |
| 8 | MFS Research Fund | 5.29% |
| 9 | MFS Mid Cap Growth Fund | 4.07% |
| 10 | MFS Mid Cap Value Fund | 4.01% |
Source: SEC Form N-PORT, period ended May 31, 2026
The top 10 make up 76.3% of the fund. See all top 25 holdings and asset mix →